Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins Against SARS-CoV-2

Keyphrases

• COVID-19 100%
• Quality Assurance 100%
• Production Assurance 100%
• Hyperimmune Immunoglobulin 100%
• Convalescent Plasma 60%
• COVID-19 Pandemic 20%
• Immunoglobulin 20%
• Low-middle Income Countries 20%
• Potential Therapeutics 20%
• Therapeutic Value 20%
• High Titer 20%
• Fc Fragment 20%
• Neutralization Activity 20%
• Immunoglobulin Preparations 20%
• Pathogen Reduction 20%

Immunology and Microbiology

• Coronavirinae 100%
• Hyperimmune Globulin 100%
• Blood Plasma 80%
• Intravenous Immunoglobulin 40%
• Immunology 40%
• Infectious Agent 20%
• Neutralization 20%
• Immunotherapy 20%
• COVID-19 20%
• Titer 20%
• Immunoglobulin Fc Fragment 20%
• Fractionation 20%

Medicine and Dentistry

• Coronavirinae 100%
• Hyperimmune Globulin 100%
• Immunoglobulin 40%
• Pathogen 20%
• Immunotherapy 20%
• COVID-19 20%
• Neutralization 20%
• Low and Middle Income Countries 20%
• Immunoglobulin Fc Fragment 20%